“LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY: Gemtuzumab ozogamicin in AML”, Mediterr J Hematol Infect Dis, vol. 12, no. 1, p. e2020020, Apr. 2020, doi: 10.4084/mjhid.2020.020.